Transforming Autologous Cell Therapy Manufacturing: Reducing Bottlenecks, Expanding Patient Access

Can Automated, Integrated Platforms Break Bottlenecks in Autologous Cell Therapy Manufacturing and Improve Patient Access?

Transforming Autologous Cell Therapy Manufacturing: Reducing Bottlenecks, Expanding Patient Access

This recorded session at ISCT 2026 Dublin highlights how integrated manufacturing platforms can help overcome key barriers to scaling autologous cell therapies, including cost, complexity, and long vein-to-vein timelines.

What You Will Learn:

Discover how Sartorius’ integrated cell therapy platform, Eveo^®️, can reduce cost per dose, shorten vein-to-vein time, and improve manufacturing scalability
Review UCL collaboration data demonstrating significant improvements in CAR-T manufacturing performance
Learn how non-viral delivery technologies, including LipidBrick^®️ Cell Ready, support greater automation, process closure, and manufacturing efficiency

Moderator:

Mark Lowdell, Ph.D., Professor of Cell and Tissue Therapy, University College London

Speakers:

Pierre Springuel, Ph.D., Cell and Gene Therapy Specialist, Corporate Research, Sartorius
Jordan Magisson, Ph.D., Scientific Support Specialist, Advanced Therapy Solutions, Sartorius

Clear form data

Please Complete the Form

First Name *

Last Name *

Email *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Complete Form To Watch The Presentation

Eveo^® Cell Therapy Platform

Sartorius Eveo^® Cell Therapy Platform brings together smart automation, quality control, and raw materials for GMP production, empowering cell therapy...

Learn More

LipidBrick^® Cell Ready

Democratizing Gene-Modified Cell Therapy, Delivering Excellence: LipidBrick^®Cell Ready is a Ready-to-Use Lipid-based Nanoparticle Solution Tailored f...

View Product